glp-1 plus How drug use is boosting beauty and wellness sales Research shows GLP-1 drugs are

SeekPeptides has compiled the latest research, phase 3 results, and safety profiles so you can understand exactly what each drug offers and where each one falls short

The headline results at 80 weeks were: 12 mg dose: average weight loss of 28.3% (approximately 70.3 lbs / 31.9 kg) 9 mg dose: average weight loss of 25.9% (approximately 64.4 lbs / 29.2 kg) 4 mg dose: average weight loss of 19.0% (approximately 47.2 lbs / 21.4 kg) Placebo: average weight loss of just 2.2% Perhaps most striking was the proportion of patients hitting bariatric-surgery-level outcomes: at the highest dose, 45.3% of participants lost 30% or more of their body weight , and 65.3% reduced their BMI to below 30 kg/m meaning they were no longer classified as living with obesity by the end of the trial

Reduced impulse purchases

Despite their health benefits, the high cost of GLP-1 medicationswhich can exceed $900 per month without insurancehas heavily restricted access, particularly for seniors living on fixed incomes

Patients with Insulin Resistance or Diabetes Since growth hormone can influence glucose metabolism, patients with pre-diabetes or type 2 diabetes should have their blood sugar monitored more closely during sermorelin therapy

What Should Before-and-After Photos Reveal About a Practices Expertise